Mangalam Drugs & Organics Ltd

MANGALAM

Company Profile

  • Business description

    Mangalam Drugs & Organics Ltd commenced its manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. The company is engaged in the manufacture and sale of APIs for various therapeutic segments, including anti-malaria, anti-retroviral, and anti-hypertensive. It is approved by the Bill Clinton Foundation. The company is actively producing Pyronaridine Tetraphosphate, a new API used in antimalarial treatments. The company has received prequalification from the World Health Organization (WHO) for both micronized and non-micronized forms of Pyronaridine Phosphate.

  • Contact

    P. D'Mello Road
    Rupam Building, 3rd Floor, No. 239
    Near General Post Office
    MumbaiMH400001
    IND

    T: +91 2222616200

    https://www.mangalamdrugs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    480

Stocks News & Analysis

stocks

The 5 best US dividend aristocrats to watch in 2026

How to avoid the dividend aristocrat trap.
stocks

Chart of the Week: Is CSL finally turning the ship around?

The beaten down healthcare giant remains cheap on turnaround potential.
stocks

ASX top pick remains cheap with narrowing brand focus

Shares remain cheap for ASX winemaker as the company narrows focus on high margin brands.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,836.7071.200.81%
CAC 408,200.8038.970.48%
DAX 4024,209.7114.400.06%
Dow JONES (US)50,616.89698.111.40%
FTSE 10010,303.8849.070.48%
HKSE24,249.29158.67-0.65%
NASDAQ25,516.13346.631.38%
Nikkei 22564,217.2738.000.06%
NZX 50 Index13,202.1651.49-0.39%
S&P 5007,343.3476.351.05%
S&P/ASX 2008,633.2069.700.81%
SSE Composite Index3,987.016.21-0.16%

Market Movers